Practice materials

Patient selection

Find resources to bring the Symplicity™ blood
pressure procedure into your practice and build
a successful hypertension program.

Start the transformation

See how the Symplicity blood pressure procedure can help your patients with hypertension.

pdf Symplicity Spyral renal denervation system brochure (.pdf) (opens new window)

Provides an overview of the procedure and the evidence that supports it, along with system details.

(opens new window)

pdf Symplicity blood pressure procedure for referring physicians (.pdf) (opens new window)

Provides an overview clinical safety and efficacy data, patient selection criteria and key guideline support.

2.1MB

A brochure explaining renal denervation for hypertension

(opens new window)

Consensus statements supporting renal denervation

Review patient guidelines for renal denervation, which includes the Symplicity blood pressure procedure, from medical societies around the world.

pdf European Society of Cardiology (ESC) Council on Hypertension and European Association of Percutaneous Cardiovascular Interventions (EAPCI) (.pdf) (opens new window)

This consensus statement recommends renal denervation as an effective treatment option for uncontrolled resistant hypertension.*

30-01-2020 |

pdf Italian Society of Arterial Hypertension (SIIA) (.pdf) (opens new window)

A flowchart in this position paper helps to identify which difficult- to-treat patients should be considered for renal denervation.

30-01-2020 |

pdf European Society for Hypertension (ESH) (.pdf) (opens new window)

This position paper recommends renal denervation as an evidence-based treatment option for a wide range of patients.

30-01-2020 | 1.2MB

pdf Taiwan Hypertension Society (THS) and Taiwan Society of Cardiology (TSC) (.pdf) (opens new window)

This consensus statement affirms that renal denervation may benefit patients, including those with resistant hypertension, and includes a patient selection tool.

30-01-2020 |

pdf European Society of Cardiology (ESC) and European Society of Hypertension (.pdf) (opens new window)

These jointly developed guidelines on managing arterial hypertension cover patient selection for renal denervation.

30-01-2020 |

pdf Asia Renal Denervation Consortium (ARDeC) (.pdf) (opens new window)

These recommendations are intended to inform healthcare professionals in Asia about renal denervation, and they include five questions to ask when considering RDN.

30-01-2020 |

Explore education resources

Explore courses, training materials, and other educational content about the Symplicity blood pressure procedure.

Find education on Medtronic Academy

CONTACT

Resistant hypertension is defined as uncontrolled office BP (≥140/≥90 mmHg), which is confirmed by out-of-office BP measurements, despite appropriate lifestyle changes and the intake of a triple-drug combination, including a diuretic at maximally tolerated doses.